Investigation of the Role of microRNA Associated with the VHL-HIFα-Dependent Pathway in Patients with Clear Cell Renal Cell Carcinoma

被引:0
|
作者
E. A. Klimentova
I. R. Gilyazova
M. A. Bermisheva
A. M. Blinnikova
R. I. Safiullin
A. A. Izmailov
B. Yang
V. N. Pavlov
E. K. Khusnutdinova
机构
[1] Institute of Biochemistry and Genetics,
[2] Ufa Federal Research Centre,undefined
[3] Russian Academy of Sciences,undefined
[4] Bashkir State Medical University,undefined
[5] Harbin Medical University,undefined
来源
Russian Journal of Genetics | 2020年 / 56卷
关键词
renal cell carcinoma; miRNA; gene expression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:363 / 369
页数:6
相关论文
共 50 条
  • [21] Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma
    Lucarelli, Giuseppe
    Rutigliano, Monica
    Ferro, Matteo
    Giglio, Andrea
    Intini, Angelica
    Triggiano, Francesco
    Palazzo, Silvano
    Gigante, Margherita
    Castellano, Giuseppe
    Ranieri, Elena
    Buonerba, Carlo
    Terracciano, Daniela
    Sanguedolce, Francesca
    Napoli, Anna
    Maiorano, Eugenio
    Morelli, Franco
    Ditonno, Pasquale
    Battaglia, Michele
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (07) : 461.e15 - 461.e27
  • [22] Microarray analysis of microRNA expression in renal clear cell carcinoma
    Huang, Y.
    Dai, Y.
    Yang, J.
    Chen, T.
    Yin, Y.
    Tang, M.
    Hu, C.
    Zhang, L.
    EJSO, 2009, 35 (10): : 1119 - 1123
  • [23] Resveratrol liposomes reverse sorafenib resistance in renal cell carcinoma models by modulating PI3K-AKT-mTOR and VHL-HIF signaling pathways
    Wang, Ligang
    Wang, Ying
    Xie, Qiqi
    Xu, Songcheng
    Yang, Chen
    Liu, Fei
    Liu, Yang
    Wang, Fuwei
    Chen, Weinan
    Li, Jianchun
    Sun, Litao
    INTERNATIONAL JOURNAL OF PHARMACEUTICS-X, 2024, 8
  • [24] VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma
    Linehan, W. Marston
    Rubin, Jeffrey S.
    Bottaro, Donald P.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (04) : 753 - 756
  • [25] Loss of vhl in the zebrafish pronephros recapitulates early stages of human clear cell renal cell carcinoma
    Noonan, Haley R.
    Metelo, Ana M.
    Kamei, Caramai N.
    Peterson, Randall T.
    Drummond, Iain A.
    Iliopoulos, Othon
    DISEASE MODELS & MECHANISMS, 2016, 9 (08) : 873 - 884
  • [26] The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?
    Cinque, Alessandra
    Minnei, Roberto
    Floris, Matteo
    Trevisani, Francesco
    CANCERS, 2022, 14 (21)
  • [27] Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma
    Patard, Jean-Jacques
    Fergelot, Patricia
    Karakiewicz, Pierre I.
    Klatte, Tobias
    Trinh, Quoc-Dien
    Rioux-Leclercq, Nathalie
    Said, Jonathan W.
    Belldegrun, Arie S.
    Pantuck, Allan J.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (02) : 395 - 400
  • [28] VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma
    Schraml, P
    Struckmann, K
    Hatz, F
    Sonnet, S
    Kully, C
    Gasser, T
    Sauter, G
    Mihatsch, MJ
    Moch, H
    JOURNAL OF PATHOLOGY, 2002, 196 (02) : 186 - 193
  • [29] MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma
    Mytsyk, Yulian
    Borys, Yuriy
    Tumanovska, Lesia
    Stroy, Dmytro
    Kucher, Askold
    Gazdikova, Katarina
    Rodrigo, Luis
    Kruzliak, Peter
    Prosecky, Robert
    Urdzik, Peter
    Dosenko, Victor
    CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 19 (04) : 515 - 524
  • [30] MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma
    Yulian Mytsyk
    Yuriy Borys
    Lesia Tumanovska
    Dmytro Stroy
    Askold Kucher
    Katarina Gazdikova
    Luis Rodrigo
    Peter Kruzliak
    Robert Prosecky
    Peter Urdzik
    Victor Dosenko
    Clinical and Experimental Medicine, 2019, 19 : 515 - 524